alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
#### Alvin Bernard TRUESDALE, Plaintiff—Appellant, v. John D. ASHCROFT; Federal Bureau of Prisons; Harley G. Lappin, Director; R. E. Holt, Southeast Regional Director for Federal Bureau of Prisons; Joseph V. Smith, Warden; *534Officer Brooks, Unit Manager at FCI-Edgefield; D. Taylor, Case Manager at FCI-Edgefield; John Doe; Jane Doe, I, Defendants—Appellees.

No. 06-7092.

United States Court of Appeals, Fourth Circuit.

Submitted: Oct. 17, 2006.

Decided: Oct. 23, 2006.

Alvin Bernard Truesdale, Appellant Pro Se. Barbara Murder Bowens, Office of the United States Attorney, Columbia, South Carolina, for Appellees.

Before NIEMEYER, KING, and DUNCAN, Circuit Judges.

Affirmed by unpublished PER CURIAM opinion.

Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).

PER CURIAM:

Alvin Bernard Truesdale appeals the district court’s orders accepting the recommendation of the magistrate judge and denying relief on his complaint filed pursuant to *Bivens v. Six Unknown Named Agents of Fed. Bureau of Narcotics,*403 U.S. 388, 91 S.Ct. 1999, 29 L.Ed.2d 619 (1971), and denying his motion for reconsideration. We have reviewed the record and find no reversible error. Accordingly, we affirm for the reasons stated by the district court. *Truesdale v. Ashcroft,*No. 8:05-cv-00078-DCN (D.S.C. Mar. 29, 30 & Apr. 21, 2006). We deny Truesdale’s pending motions to disqualify the Defendants’ counsel, to appoint counsel for him, to hold these proceedings in abeyance or to compel, for a conference, and for publication of the opinion in this case. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

*AFFIRMED.*
<PAGE>





                                                                  Exhibit 23.2

                         CONSENT OF INDEPENDENT AUDITORS


We consent to the incorporation by reference in the Registration Statement on
Form S-8 No.333-49387 pertaining to the 1992 Amended Stock Option Plan of Allied
Healthcare International Inc. and the Registration Statement on Form S-3
No.333-90890 pertaining to the registration of 23,497,157 shares of Allied
Healthcare International Inc.'s common stock, of our report dated November 8,
2002, with respect to the consolidated financial statements and schedule of
Allied Healthcare International Inc. included in this Annual Report (Form 10-K)
for the year ended September 30, 2003.


                                                           /s/ Ernst & Young LLP



New York, New York
December 22, 2003
# Mercedes-Benz USA Request for Partial Extension of Priority Group 9 Sufficient Supply and Remedy Launch Deadline

                                                                          Download file:                       Mercedes-Benz USA Request for Partial Extension of Priority Group 9 Sufficient Supply and Remedy Launch Deadline
Exhibit 23.1

                         CONSENT OF INDEPENDENT AUDITORS


The Board of Directors
PennCorp Financial Group, Inc.:

The audits  referred to in our report dated March 31, 1999  included the related
financial statement schedules as of December 31, 1998, and for each of the years
in the  three-year  period  ended  December  31, 1998,  included  herein.  These
financial   statement   schedules  are  the   responsibility  of  the  Company's
management.  Our  responsibility  is to express  an  opinion on these  financial
statement  schedules  based  on our  audits.  In  our  opinion,  such  financial
statements  taken  as a whole,  present  fairly  in all  material  respects  the
information set forth therein.

We consent to the incorporation by reference in the registration statements (No.
333-13285) on Form S-3 and (Nos. 333-48629, 333-48631 and 333-48637) on Form S-8
of PennCorp Financial Group, Inc. of our reports included herein relating to the
consolidated  balance sheets of PennCorp  Financial Group, Inc. and subsidiaries
as of December 31, 1998 and 1997,  and the related  consolidated  statements  of
operations and comprehensive income (loss), changes in shareholders' equity, and
cash flows for each of the years in the  three-year  period  ended  December 31,
1998,  and all related  schedules,  and to the  reference  to our firm under the
heading  "Experts"  in the  prospectus  related  to the  Form  S-3  registration
statement.

                                              KPMG LLP




Dallas, Texas
March 31, 1999
EXHIBIT 31.2  CHIEF FINANCIAL OFFICER CERTIFICATION  I, P. Morgan McCune, Chief Financial Officer, certify that:  1. I have reviewed this quarterly report on Form 10-K of Triple A Medical, Inc.  2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;  3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;  4. The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:  a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;  b) evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and  c) disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and  5. The registrants other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of registrants board of directors (or persons performing the equivalent functions):  a) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect  the registrants ability to record, process, summarize and report financial information; and  b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.   Date: April 6, 2008        /s/ P. Morgan McCune   P. Morgan McCune     Chief Financial Officer
[Federal Register Volume 74, Number 95 (Tuesday, May 19, 2009)]
[Notices]
[Page 23425]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-11585]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
National Cancer Institute Clinical Trials and Translational Research 
Advisory Committee. The meeting will be open to the public, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.

    Name of Committee: National Cancer Institute Clinical Trials and 
Translational Research Advisory Committee.
    Date: July 15, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: Update on the progress of the implementation of the 
Clinical Trials Working Group and the Translational Research Working 
Group Reports.
    Place: National Institutes of Health, Building 31, 6th Floor, C-
Wing, 31 Center Drive, Conference Room 10, Bethesda, MD 20892.
    Contact Person: Sheila A. Prindiville, MD, Director, 
Coordinating Center for Clinical Trials, Office of the Director, 
National Cancer Institute, National Institutes of Health, 6120 
Executive Blvd., 3rd Floor Suite, Bethesda, MD 20892, 301-451-5048, 
<a href="/cdn-cgi/l/email-protection#95e5e7fcfbf1fce3e6d5f8f4fcf9bbfbfcfdbbf2fae3"><span class="__cf_email__" data-cfemail="08787a61666c617e7b486569616426666160266f677e">[email protected]</span></a>.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: May 12, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-11585 Filed 5-18-09; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
EXHIBIT 32.1  SARBANES-OXLEY SECTION 906 CERTIFICATION  In connection with the Annual Report of International Barrier Technology Inc. (the Company) on Form 10-KSB for the period ended June 30, 2006 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Michael Huddy, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:  (1)  The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and (2)  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.  /s/ Michael Huddy Michael Huddy President/CEO October 06, 2006
EXHIBIT 32.1

Certification Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United
States Code), I, Wm. Stacy Locke, President and Chief Executive Officer of Pioneer Drilling Company, a Texas corporation (the Company), hereby certify, to my knowledge, that:



| | (1) | the Companys Quarterly Report on Form 10-Q for the quarter ended June 30, 2007 (the Report) fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                      |  |  |  |  |  |                                                      
|--------------------- |  |  |  |  |  | -----------------------------------------------------
|                      |  |  | 
|Dated: August 2, 2007 |  |  |  |  |  | /s/ Wm. Stacy Locke                                  
|                      |  |  |  |  |  | Wm. Stacy Locke President and Chief Executive Officer
**Deloitte****Deloitte & Touche LLP**JPMorgan  Chase  Tower 2200 Ross Avenue, Suite 1600 D a l l a s ,   TX  75201-6778  USA Tel: +1 214 840 7000 www.deloitte.com  **REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**Board of Directors and Shareholders EMC Mortgage Corporation We have examined management's assertions, included in paragraphs 1 through 4 in the accompanying Certification Regarding Compliance with Applicable Servicing Criteria, that EMC Mortgage Corporation (a wholly owned subsidiary of The Bear Steams Companies Inc.) (the "Company") complied with the servicing criteria set forth in Item 1122(d) of the Securities and Exchange Commission's Regulation AB for the asset-backed securities transactions for which the Company acted as servicer involving first and second lien, prime and sub-prime residential mortgage loans, that were completed on or after January 1, 2006 and that were registered with the Securities and Exchange Commission pursuant to the Securities Act of 1933 (the "Platform") as of and for the year ended December 31, 2007, excluding criteria 1122 (d)(1)(iii), (d)(3)(i)C, (d)(4)(xi), (d)(4)(xii), (d)(4)(xiii), and (d)(4)(xv) which management has determined are not applicable to the activities performed by the Company with respect to the Platform. Management is responsible for the Company's compliance with the servicing criteria. Our responsibility is to express an opinion on management's assertion about the Company's compliance with the servicing criteria based on our examination. Our examination was conducted in accordance with attestation standards established by the American Institute of Certified Public Accountants, as adopted by the Public Company Accounting Oversight Board (United States), and, accordingly, included examining, on a test basis, evidence about the Company's compliance with the applicable servicing criteria, including tests on a sample basis of the servicing activities related to the Platform, determining whether the Company performed those selected activities in compliance with the servicing criteria during the specified period, and performing such other procedures as we considered necessary in the circumstances. Our procedures were limited to selected servicing activities performed by the Company during the period covered by this report and, accordingly, such samples may not have included servicing activities related to each asset-backed transaction included in the Platform. Further, an examination is not designed to detect noncompliance arising from errors that may have occurred prior to the period specified above that may have affected the balances or amounts calculated or reported by the Company during the period covered by this report. We believe that our examination provides a reasonable basis for our opinion. Our examination does not provide a legal determination on the Company's compliance with the servicing criteria. In our opinion, management's assertion that the Company complied with the aforementioned applicable servicing criteria as of and for the year ended December 31, 2007 for the Platform is fairly stated in all material respects. /s/ Deloitte & Touche LLP March 14, 2008
## F IFTH 

## D ISTRICT 

## C OURT OF 

## A PPEAL 

## S TATE OF 

## F LORIDA

_____________________________ Case No. 5 D23- 229 LT Case No. 16

- 2022 -CF- 2019 -AXXX

_____________________________ A LEXANDER D AVID R OTHERMEL , Appellant,

v. S TATE OF FLORIDA , Appellee.

_____________________________ On appeal from the Circuit Court for Duval County. Adrian G. Soud, Judge. Jessica J. Yeary, Public Defender, and Tyler Kemper Payne, Assistant Public Defender, Tallahassee, for Appellant. Ashley Moody, Attorney General, and Heather Flanagan Ross, Assistant Attorney General, Tallahassee, for Appellee. January 9, 2024

P ER C URIAM . A FFIRMED . E DWARDS , C.J., M AKAR , and E ISNAUGLE , JJ., concur.2 _____________________________ Not fin al until disposition of any timely and authorized motion under Fla. R. App. P. 9.330 or 9.331 .

_____________________________
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Small Business Administration

          - [Disaster Declaration #11732 and #11733] 

# AGENCY:

U.S. Small Business Administration. 

# ACTION:

Amendment 2. 

# SUMMARY:

This is an amendment of the Presidential declaration of a major disaster for the State of Florida (FEMA-1831-DR), dated 04/28/2009. 

*Incident:*                         Severe Storms, Flooding, Tornadoes, and Straight-line Winds.                     

*Incident Period:*                         03/26/2009 through 05/05/2009.                     

# DATES:

*Effective Date:*                         05/06/2009.                     

*Physical Loan Application Deadline Date:*                         06/29/2009.                     

*EIDL Loan Application Deadline Date:*                         01/28/2010.                     

# ADDRESSES:

Submit completed loan applications to:  U.S. Small Business Administration, Processing and Disbursement Center, 14925 Kingsport Road,  Fort Worth, TX 76155. 

# FOR FURTHER INFORMATION CONTACT:

A. Escobar, Office of Disaster Assistance, U.S. Small Business Administration, 409 3rd Street, SW., Suite 6050, Washington, DC 20416. 

# SUPPLEMENTARY INFORMATION:

The notice of the President's major disaster declaration for the State of Florida, dated 04/28/2009 is hereby amended to establish the incident period for this disaster as beginning 03/26/2009 and continuing through 05/05/2009. 

All other information in the original declaration remains unchanged. 

(Catalog of Federal Domestic Assistance Numbers 59002 and 59008)

James E. Rivera, 

Acting Associate Administrator for Disaster Assistance.

 [FR Doc. E9-11295 Filed 5-13-09; 8:45 am] 

BILLING CODE 8025-01-P
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          APR-30-2001
<PERIOD-END>                               JUL-31-2000
<CASH>                                           88650
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                 88650
<PP&E>                                             513
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                   89163
<CURRENT-LIABILITIES>                                0
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        137000
<OTHER-SE>                                     ( 47837)
<TOTAL-LIABILITY-AND-EQUITY>                     89163
<SALES>                                              0
<TOTAL-REVENUES>                                 80692
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                 18874
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                  61818
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                              61818
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     61818
<EPS-BASIC>                                        0
<EPS-DILUTED>                                        0


</TABLE>
IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 15-40033

Conference Calendar

UNITED STATES OF AMERICA,

Plaintiff-Appellee

v.

JAVIER BARRON-HERNANDEZ,

Defendant-Appellant

Appeal from the United States District Court

for the Southern District of Texas

USDC No. 1:14-CR-273-1

Before JONES, SOUTHWICK, and COSTA, Circuit Judges.

PER CURIAM:*

The attorney appointed to represent Javier Barron-Hernandez has 

moved for leave to withdraw and has filed a brief in accordance with Anders v. 

California, 386 U.S. 738 (1967), and United States v. Flores, 632 F.3d 229 (5th 

Cir. 2011). Barron-Hernandez has not filed a response. We have reviewed 

counsel’s brief and the relevant portions of the record reflected therein. We 

concur with counsel’s assessment that the appeal presents no nonfrivolous 

 

* Pursuant to 5TH CIR. R. 47.5, the court has determined that this opinion should not 

be published and is not precedent except under the limited circumstances set forth in 5TH 

CIR. R. 47.5.4.

United States Court of Appeals

Fifth Circuit

FILED

December 15, 2015

Lyle W. Cayce

Clerk

 Case: 15-40033 Document: 00513308407 Page: 1 Date Filed: 12/15/2015
No. 15-40033

2

issue for appellate review. Accordingly, counsel’s motion for leave to withdraw 

is GRANTED, counsel is excused from further responsibilities herein, and the 

APPEAL IS DISMISSED. See 5TH CIR. R. 42.2.

 Case: 15-40033 Document: 00513308407 Page: 2 Date Filed: 12/15/2015